Decoy Therapeutics DCOY Insider Ownership

NASDAQ DCOY
$1.08 -0.06 (-5.29%)
As of: Oct 21, 2026 · 3:55 PM EDT

Insider Holdings by Owner

68.78K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
13.00%
▲+12.61% pp QoQ
Shares Held by Insiders
69.17K
filed for Sep 2026
▲+3,185.75% QoQ
Shares Outstanding
531.97K
531,968 shares
Direct Holdings
68.75K
Indirect: 417
Net Shares Traded (QoQ)
+67.06K
net buying in Sep 2026
Insiders Holding Shares
12
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Over the trailing 12 months, DCOY insiders bought $19,740 worth of shares and sold $17 worth in open-market trades.

Form 4 Holdings

Insiders Holding DCOY

Insiders 12
Shares held 68.78K
Of outstanding 12.93%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Frederick Ii Pierce Chief Executive Officer 34,844 0 34,844 50.7% 02 Sep, 2026
2 Mark J Rosenblum Chief Financial Officer 11,363 0 11,363 16.5% 02 Sep, 2026
3 Barbara Louise Hibner Chief Scientific Officer 4,216 0 4,216 6.1% 02 Sep, 2026
4 Peter Klaus Marschel Chief Business Officer 3,900 0 3,900 5.7% 02 Sep, 2026
5 Arnold C Hanish Director 3,418 0 3,418 5.0% 02 Sep, 2026
6 William K. Mcvicar Director 3,002 0 3,002 4.4% 02 Sep, 2026
7 Jonathan I Lieber Director 2,002 0 2,002 2.9% 02 Sep, 2026
8 Tess Burleson Director 2,002 0 2,002 2.9% 02 Sep, 2026
9 Paul Lammers Director 2,001 0 2,001 2.9% 02 Sep, 2026
10 Patricia G. Gauthier Director 2,000 0 2,000 2.9% 02 Sep, 2026
11 David J. Arthur Chief Executive Officer 33 0 33 0.0% 15 Feb, 2023
12 Bruce J Jr. Mccreedy Director 1 0 1 0.0% 05 Jan, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

278 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
31 Aug, 2026 Peter Klaus Marschel Chief Business Officer Acquired A 3,900 $0.00 $0 3,900 Direct
31 Aug, 2026 Arnold C Hanish Director Acquired A 3,000 $0.00 $0 3,418 Direct
31 Aug, 2026 William K. Mcvicar Director Acquired A 3,000 $0.00 $0 3,002 Direct
31 Aug, 2026 Jonathan I Lieber Director Acquired A 2,000 $0.00 $0 2,002 Direct
31 Aug, 2026 Tess Burleson Director Acquired A 2,000 $0.00 $0 2,002 Direct
31 Aug, 2026 Patricia G. Gauthier Director Acquired A 2,000 $0.00 $0 2,000 Direct
31 Aug, 2026 Mark J Rosenblum Chief Financial Officer Acquired A 9,682 $0.00 $0 11,363 Direct
31 Aug, 2026 Barbara Louise Hibner Chief Scientific Officer Acquired A 4,216 $0.00 $0 4,216 Direct
31 Aug, 2026 Paul Lammers Director Acquired A 2,000 $0.00 $0 2,001 Direct
31 Aug, 2026 Frederick Ii Pierce Chief Executive Officer Acquired A 33,455 $0.00 $0 34,844 Direct
30 Dec, 2025 Arnold C Hanish Director Disposed S 15 $7.68 $115 417 Indirect
30 Dec, 2025 Arnold C Hanish Director Disposed S 12 $7.68 $92 0 Direct
20 Nov, 2025 Arnold C Hanish Director Acquired P 5,000 $8.98 $44.89K 418 Indirect
20 Nov, 2025 Mark J Rosenblum Exec Vp Finance, Cfo Acquired P 20,000 $9.60 $192.00K 1,681 Direct
11 Apr, 2024 David J. Arthur Chief Executive Officer Acquired A 20,500 $0.00 $0 14 Direct
20 Feb, 2024 William K. Mcvicar Director Acquired A 20,500 $0.00 $0 14 Direct
20 Feb, 2024 Paul Lammers Director Acquired A 20,500 $0.00 $0 14 Direct
20 Feb, 2024 Jonathan I Lieber Director Acquired A 20,500 $0.00 $0 14 Direct
20 Feb, 2024 Mark J Rosenblum Exec Vp Finance, Cfo Acquired A 22,500 $0.00 $0 16 Direct
20 Feb, 2024 Arnold C Hanish Director Acquired A 20,500 $0.00 $0 14 Direct